非T2型哮喘的治疗进展  

Recent progress in the treatment of non-T2 asthma

作　　者：隆海燕[1] 韦江红[1] LONG Haiyan;WEI Jianghong(Department of Respiratory and Critical Care Medicine,Affiliated Hospital of Guilin Medical College,Guilin 541000,China)

机构地区：[1]桂林医学院附属医院呼吸与危重症医学科,广西桂林541000

出　　处：《细胞与分子免疫学杂志》2024年第12期1127-1132,共6页Chinese Journal of Cellular and Molecular Immunology

基　　金：国家自然科学基金(81960007)。

摘　　要：非T2型哮喘也称为非嗜酸性粒细胞性哮喘或低T2型哮喘,不存在2型炎症标志物,往往与激素不敏感及重度哮喘相关。本文就非T2型哮喘的药物治疗进展进行综述。Non-T2 asthma,also known as non-eosinophilic asthma or low T2 asthma,does not have markers of type 2 inflammation and is often associated with hormone insensitivity and severe asthma.This article reviews the progress in drug therapy for non-T2 asthma.

关 键 词：非T2型哮喘 Th1/Th17细胞 治疗进展 免疫疗法 综述 

分 类 号：R730.51[医药卫生—肿瘤] R256.12[医药卫生—临床医学] G353.11[文化科学—情报学]